Abstract
Cryopreservation of peripheral blood hematopoietic stem cells (PBHSC) occurs frequently in the setting of autologous stem cell transplantation. The long-term viability of these cells is an important issue as these patients may eventually experience disease relapse. Previous reports have demonstrated that cryopreserved PBHSCs can retain viability for up to 15 years. We describe the effects of long-term cryopreservation on progenitor viability and activity at our institution.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
